about
Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edemaClinical relevance of quantified fundus autofluorescence in diabetic macular oedema.Potential measurement errors due to image enlargement in optical coherence tomography imaging.Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusionSubfoveal serous retinal detachment associated with extramacular branch retinal vein occlusion.Association between cystoid spaces on indocyanine green hyperfluorescence and optical coherence tomography after vitrectomy for diabetic macular oedema.Structural changes in individual retinal layers in diabetic macular edemaEphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.Photocoagulation guided by wide-field fundus autofluorescence in eyes with asteroid hyalosis.[Retinal function evaluated by electroretinogram in diabetic retinopathy].Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion.Optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy.SDF-1/CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis.Time-lapse imaging of retinal angiogenesis reveals decreased development and progression of neovascular sprouting by anecortave desacetate.Macular migration toward the optic disc after inner limiting membrane peeling for diabetic macular edema.Association between fluorescein leakage and optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy.[Intravitreal tissue plasminogen activator for treatment of central retinal vein occlusion associated with diabetic retinopathy].Branch retinal vein occlusion-associated subretinal hemorrhage.Morphologic and functional changes in retinal vessels associated with branch retinal vein occlusion.Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa.Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.Time-lapse imaging of vitreoretinal angiogenesis originating from both quiescent and mature vessels in a novel ex vivo system.Parallelism as a novel marker for structural integrity of retinal layers in optical coherence tomographic images in eyes with epiretinal membrane.Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy.Relationship between fluorescein pooling and optical coherence tomographic reflectivity of cystoid spaces in diabetic macular edema.Disrupted foveal photoreceptors after combined cystoid spaces and retinal detachment in branch vein occlusion treated with bevacizumab.Segmentational analysis of retinal thickness after vitrectomy in diabetic macular edema.Retinal vessel tortuosity associated with central retinal vein occlusion: an optical coherence tomography study.Qualitative and quantitative characteristics of near-infrared autofluorescence in diabetic macular edema.Integrative understanding of macular morphologic patterns in diabetic retinopathy based on self-organizing map.Association between retinal venular dilation and serous retinal detachment in diabetic macular edema.Age- and hypertension-dependent changes in retinal vessel diameter and wall thickness: an optical coherence tomography study.Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion.Cyclic stretch-induced reactive oxygen species generation enhances apoptosis in retinal pericytes through c-jun NH2-terminal kinase activation.Disorganized retinal lamellar structures in nonperfused areas of diabetic retinopathy.[Peripherin/RDS gene mutation in a patient with choroidal neovascularization]Photoreceptor status after resolved macular edema in branch retinal vein occlusion treated with tissue plasminogen activatorIntravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion
P50
Q33563100-C12668DC-C7C9-4726-8926-2538717F2BCFQ35599050-E36C69CD-F84E-4927-9578-9D2FB1EF085CQ35646195-704B58D7-5823-430B-A4A9-1043FE4831DEQ36035854-77CF7DDE-FF27-4AE5-93D5-E3E957F8182FQ36587744-DDF1ACEE-D64F-4E2F-A5A6-61552147EE0BQ37697863-9219E068-740D-496A-969D-81800C32A881Q38145185-3C9CCBD1-E209-4F2E-918C-9F9EF07145ADQ38404246-82037F39-09EB-401E-B357-C1716E40D7F5Q42563395-DB519753-3AB5-41D0-A395-D4708D281BD7Q42732417-FE518909-46E7-4B5A-8505-C735DCBA3C52Q42770019-B7A122FC-8789-4FA4-AA0C-590D6A03D281Q42882927-C584B2DE-6AAD-4345-86A2-9273451A349FQ43150970-1AB04827-7D26-4B62-AC97-8B9516DC6579Q43230315-6323532D-4401-460A-A07F-B673F761387BQ43860953-9839CA9C-8502-408D-AED8-79ED2015E95CQ45040892-EE2DFD38-15F7-4721-A187-A673809F6845Q46004294-901D8BF0-0910-464D-A0BB-A54D29357BB5Q46166025-F4080B39-63BA-49E8-9813-8DD8FC439879Q46389602-4C3221EF-F805-45F9-BCDF-93A53233588AQ46667958-24EC2B33-0C5B-4D27-8909-0FCADDAD202AQ46777192-FBAA673A-8C2B-4EF7-8C76-D7C12877876CQ46881054-C8D2989D-4868-4B69-BE67-D63B44F4A66AQ50707304-3F2D6D75-5208-4799-9AA4-E661EDBAAA24Q51150099-86D75462-DD37-435F-8BD2-4A57E14258E4Q52601707-303E1E2C-26FD-47F6-A0F6-EFC4DD586088Q52605849-69021F82-F734-47E1-BD64-EB7E0931E92BQ52621660-BDDCB81A-F7AA-4606-A5DA-CDE0D432EE03Q52624013-7FD2D31A-6889-4C68-9ACA-BACE41BA2578Q52629445-9525B344-B4C4-43F4-9151-5393D9DD4B69Q52646094-D7DD1480-4DD5-474D-98E6-5F465B6F0BC2Q52646942-92E18947-9D6E-42B3-8D83-46C270D9B6CBQ52648369-98864BCF-4369-48E6-9973-881D36A9F510Q53097507-F1886F6A-B247-4E06-86E0-A2E75FA79EA2Q53100787-E29312FB-7455-4760-AAAC-D308262F7428Q53206284-8F54352A-4881-4AC8-B4F9-9E1F291097E2Q53583679-2A4B5109-9313-4852-92B1-EC0FD47A543EQ53595752-52884B0C-9FE7-4228-B61A-525278A1D58FQ61479635-29C92750-109C-4C9F-897A-C5D4064F342DQ79450386-83243B82-38EB-4987-BB33-19DA9D1FAEB9Q80021649-926592B7-5DDF-41FC-9317-A3405FA874DE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tomoaki Murakami
@ast
Tomoaki Murakami
@en
Tomoaki Murakami
@es
Tomoaki Murakami
@sl
type
label
Tomoaki Murakami
@ast
Tomoaki Murakami
@en
Tomoaki Murakami
@es
Tomoaki Murakami
@sl
prefLabel
Tomoaki Murakami
@ast
Tomoaki Murakami
@en
Tomoaki Murakami
@es
Tomoaki Murakami
@sl
P106
P31
P496
0000-0002-0314-8807